Positions 51–62 of 62.
Posting this as a discussion rather than a claim: amylin: what the trials say vs what this community says. Independent purity data on this compound is sparse compared…
am I the only one who found amylin harder than the injections, and I want the answer with the reasoning attached rather than just the conclusion. Combination and…
small win: cagrilintide stopped being a problem at week 75. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Six-word version is the title — week 68 check-in — 34kg down, nausea manageable, one thing confusing me — and the rest is context. week 68 and 34kg. Those are measured,…
Send the vial, get the number. Third-party purity and identity testing, results published to you regardless of what they say.
Test a vialSponsoredEst. 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. There is a fair chance the vial you are about to send for testing started here. Batch-specific COA as standard.
glbiochem.netHere it is: week 17 check-in — 4kg down, fatigue manageable, one thing confusing me. One person, one log, no control group, so read it accordingly. Hard numbers: week…
small win: cagrilintide stopped being a problem at week 60. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Trying to get a straight answer on this: why does the satiety feel qualitatively different. Reading the trial literature on this without misleading yourself. Separate…
The title is the whole question — what changed for me between month 9 and month 14 — but here is why I am asking. Dosing intuitions from the GLP-1 boards do not…
three years of CagriSema threads, summarised so you do not have to read them. I have gone back and forth on this for months. Combination and monotherapy arms must be…
Question in the title, detail here: someone explain satiety to me like I have not read a paper in years. Amylin is co-secreted with insulin and acts on satiety and…
Here it is: 23 months in and satiety is still the thing I get wrong. One person, one log, no control group, so read it accordingly. The numbers the title promised,…
Genuine question, and the title is the question: how do you actually verify satiety. Bought small deliberately because the evidence base is thin. That felt like the…
Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference